|
시장보고서
상품코드
2049412
중합효소 연쇄 반응(PCR) 시장 보고서 : 제품별, 최종사용자별, 지역별(2026-2034년)Polymerase Chain Reaction Market Report by Product, End User, and Region 2026-2034 |
||||||
세계의 중합효소 연쇄 반응(PCR) 시장 규모는 2025년에 87억 달러에 달했습니다. 향후 IMARC Group은 2026년부터 2034년까지 CAGR 5.93%를 기록하며 2034년까지 시장 규모가 148억 달러에 달할 것으로 예측하고 있습니다.
중합효소 연쇄 반응(PCR)은 DNA의 일부분을 여러 번 복제하기 위해 사용되는 분자진단 기술입니다. PCR 장비는 자동적이고 사전 프로그래밍된 절차에 따라 시료의 온도를 제어하고 수백만 개의 DNA 염기서열 사본을 정확하게 생성하는 데 사용됩니다. 이 기술은 결핵, 후천성면역결핍증후군(AIDS), 감염성 질환, 라임병 등의 검출에 도움이 되는 병원성 미생물의 동정 및 배양을 수행합니다. 따라서 PCR은 유전학, 생명공학, 분자생물학, 신약개발, 임상 진단 등 다양한 생명과학 관련 분야에서 폭넓게 응용되고 있습니다.
세계 중합효소 연쇄 반응(PCR) 시장 동향 및 촉진요인:
다양한 감염성 및 유전성 질환의 유병률 증가는 시장 성장을 이끄는 주요 요인 중 하나입니다. 전 세계적으로 만성질환에 취약한 노년층이 증가하고 있는 것도 산업 성장에 힘을 실어주고 있습니다. 신종 코로나바이러스 감염증(COVID-19)의 대유행은 감염의 정확한 진단과 조기 발견을 위한 PCR 기술의 보급을 더욱 촉진했습니다. 또한, PCR 장비는 전체 공정에서 오염 위험과 인위적인 실수 가능성을 최소화하는 데에도 도움이 됩니다.
맞춤형 의료 및 정밀의료에 대한 수요 증가도 시장에 밝은 전망을 가져다주고 있습니다. 이러한 의료는 PCR 기술을 이용하여 환자 개개인에 맞는 맞춤형 치료법 제공을 목표로 하고 있습니다. 임상 진단 분야에서의 적용 확대, 생명공학 분야의 광범위한 연구개발(R&D) 활동 등 다른 요인들도 시장 성장을 견인할 것으로 예상됩니다.
본 보고서에서 답변하는 주요 질문
- 지금까지 세계 중합효소 연쇄 반응(PCR) 시장의 동향은 어떠했으며, 향후 몇 년 동안 어떻게 변화할 것인가?
- COVID-19는 세계 중합효소 연쇄 반응(PCR) 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은 어디인가?
- 제품별로 보면 시장 내역은 어떠한가?
- 최종사용자별 시장 현황은 어떠한가?
- 이 산업의 가치사슬에서 각 단계는 어떤 역할을 하는가?
- 이 산업의 주요 촉진요인과 과제는 무엇인가?
- 세계 중합효소 연쇄 반응(PCR) 시장의 구조는 무엇이며 주요 업체는 누구인가?
- 업계 내 경쟁은 어느 정도 치열한가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 중합효소 연쇄 반응(PCR) 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 최종사용자별
제8장 시장 내역 : 지역별
제9장 SWOT 분석
제10장 밸류체인 분석
제11장 Porter's Five Forces 분석
제12장 가격 분석
제13장 경쟁 구도
KSM 26.06.09The global polymerase chain reaction market size reached USD 8.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 14.8 Billion by 2034, exhibiting a growth rate (CAGR) of 5.93% during 2026-2034.
Polymerase chain reaction (PCR) refers to a molecular diagnostic technique that is used to make multiple copies of a segment of DNA. A PCR machine is used to manipulate the temperature of the sample in an automatic and pre-programmed procedure to generate millions of copies of DNA sequencing accurately. This technology identifies and cultures disease-causing microorganisms, which aid in the detection of tuberculosis, Acquired Immunodeficiency Syndrome (AIDS), infections and Lyme disease. Owing to this, it finds extensive applications across various life science-related fields, such as genetics, biotechnology, molecular biology, drug discovery and clinical diagnostics.
GLOBAL POLYMERASE CHAIN REACTION MARKET TRENDS AND DRIVERS:
The increasing prevalence of various infectious diseases and genetic disorders is one of the key factors driving the growth of the market. The rising geriatric population across the globe, which is more prone to chronic medical ailments, is also driving the industry growth. The outbreak of the coronavirus disease (COVID-19) pandemic has further led to the widespread adoption of PCR technologies for accurate diagnosis and early detection of infections. PCR devices also aid in minimizing the risks of contamination and the chances of human errors in the entire process.
The increasing demand for personalized and precision medicines is also creating a positive outlook for the market. These medicines aim to provide tailor-made therapies, which are identified and developed using PCR technologies. Other factors, including the increasing application in clinical diagnostics, along with extensive research and development (R&D) activities in the field of biotechnology, are expected to drive the market further.
KEY MARKET SEGMENTATION:
Breakup by Product:
- Instruments
- Standard PCR Systems
- Digital PCR Systems
- Real-Time PCR Systems
- Reagents and Consumables
- Software and Services
Breakup by End User:
- Academic and Research Institutes
- Clinical Diagnostics Labs and Hospitals
- Pharmaceutical and Biotechnology Companies
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., BD (Becton, Dickinson and Company), BioMerieux (Institut Merieux SA), Bio-RAD Laboratories Inc., F. Hoffmann-La Roche AG, Fluidigm Corporation, Merck KGaA, Perkinelmer Inc., Promega Corporation, Takara Bio Inc. and Thermo Fisher Scientific Inc.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global polymerase chain reaction market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global polymerase chain reaction market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global polymerase chain reaction market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Polymerase Chain Reaction Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Breakup by Type
- 6.1.2.1 Standard PCR Systems
- 6.1.2.1.1 Market Trends
- 6.1.2.1.2 Market Forecast
- 6.1.2.2 Digital PCR Systems
- 6.1.2.2.1 Market Trends
- 6.1.2.2.2 Market Forecast
- 6.1.2.3 Real-Time PCR Systems
- 6.1.2.3.1 Market Trends
- 6.1.2.3.2 Market Forecast
- 6.1.2.1 Standard PCR Systems
- 6.1.3 Market Forecast
- 6.2 Reagents and Consumables
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by End User
- 7.1 Academic and Research Institutes
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Clinical Diagnostics Labs and Hospitals
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Pharmaceutical and Biotechnology Companies
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Agilent Technologies Inc.
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 BD (Becton, Dickinson and Company)
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 BioMerieux (Institut Merieux SA)
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Bio-RAD Laboratories Inc.
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 F. Hoffmann-La Roche AG
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 Fluidigm Corporation
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.7 Merck KGaA
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Perkinelmer Inc.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.9 Promega Corporation
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.10 Takara Bio Inc.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.11 Thermo Fisher Scientific Inc.
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 Financials
- 13.3.11.4 SWOT Analysis
- 13.3.1 Agilent Technologies Inc.
